Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular pathways in bladder cancer.

Stephen G Williams, John P Stein

    Urological Research
    |November 20, 2004
    PubMed
    Summary
    This summary is machine-generated.

    This review outlines molecular and genetic events in bladder cancer progression. Understanding these changes is key to developing new diagnostic markers and targeted therapies for transitional cell carcinoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editorial Commentary.

    Urology practice·2023
    Same author

    Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
    Same author

    Disparities in Stage at Diagnosis in an Equal-access Integrated Delivery System: A Retrospective Cohort Study of 7244 Patients With Bladder Cancer.

    Clinical genitourinary cancer·2020
    Same author

    AUTHOR REPLY.

    Urology·2019
    Same author

    Care Quality and Variability in the Use of Intravesical Therapy for Initial Treatment of Nonmuscle Invasive Bladder Cancer Within a Large, Diverse Integrated Delivery System.

    Urology·2019
    Same author

    Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System.

    The Permanente journal·2019
    Same journal

    Erratum to: Is routine ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy for lower ureteral stones larger than 1 cm?

    Urological research·2017
    Same journal

    2002 30(th) Munich Endourological Symposium 10-11 October 2002.

    Urological research·2014
    Same journal

    Ellagica acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).

    Urological research·2014
    Same journal

    Biomolecular mechanism of urinary stone formation involving osteopontin.

    Urological research·2012
    Same journal

    Renal tubular epithelial cell injury, apoptosis and inflammation are involved in melamine-related kidney stone formation.

    Urological research·2012
    Same journal

    Role of 1 week of antibiotic prophylaxis before percutaneous nephrolithotomy.

    Urological research·2012
    See all related articles

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Bladder cancer, particularly transitional cell carcinoma (TCC), involves complex molecular and genetic alterations.
    • Current research focuses on identifying and characterizing TCC subtypes and their biological potential.

    Discussion:

    • Key molecular events include chromosomal alterations driving carcinogenesis, cell cycle dysregulation promoting proliferation, and angiogenesis facilitating metastasis.
    • The accumulation of these genetic and molecular changes dictates tumor phenotype and clinical behavior.

    Key Insights:

    • Conventional histopathologic grading and staging of bladder tumors are insufficient for accurate prognosis.
    • Advanced laboratory techniques offer insights into bladder cancer development and progression, though clinical application is limited.

    Related Experiment Videos

    Outlook:

    • The development of reliable prognostic markers is crucial for predicting tumor behavior and therapeutic response.
    • Future strategies aim to utilize this molecular understanding for novel prevention and treatment approaches targeting early disease events.